In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Compass Therapeutics Inc’s stock clocked out at $2.69, up 2.67% from its previous closing price of $2.62. In other words, the price has increased by $2.67 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
To gain a deeper understanding of CMPX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.33 and its Current Ratio is at 8.33. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 24, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
On February 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $12.Piper Sandler initiated its Overweight rating on February 19, 2025, with a $12 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 27 ’25 when Schuetz Thomas J. bought 10,000 shares for $2.11 per share. The transaction valued at 21,100 led to the insider holds 6,480,825 shares of the business.
GORDON CARL L sold 3,571,428 shares of CMPX for $5,678,571 on Apr 09 ’25. The Director now owns 0 shares after completing the transaction at $1.59 per share. On Apr 09 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, sold 3,571,428 shares for $1.59 each. As a result, the insider received 5,678,571 and left with 0 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 437.62 while its Price-to-Book (P/B) ratio in mrq is 3.37.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 28.29%, while the 200-Day Moving Average is calculated to be 29.90%.
Shares Statistics:
A total of 138.28M shares are outstanding, with a floating share count of 87.95M. Insiders hold about 36.40% of the company’s shares, while institutions hold 43.20% stake in the company.
